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In the UK, patients normally see their general practitioner first and 86% of the health needs of the
population are managed in general practice, with 14% being referred to specialist/hospital care.
Early diagnosis is the privilege of general practice since general practitioners make most medical
diagnoses in the NHS. Their historic aim has been to diagnose as early as possible and if possible
before patients are aware of symptoms. Over time, diagnoses are being made earlier in the tra-
jectory of chronic diseases and pre-symptomatic diagnoses through tests like cervical screening.
Earlier diagnosis benefits patients and allows earlier treatment. In diabetes, the presence of
lower HbA1c levels correlates with fewer complications. Methodologically, single practice
research means smaller populations but greater ability to track patients and ask clinicians about
missing data. All diagnoses of type 2 diabetes, wherever made, were tracked until death or trans-
fer out. Clinical opportunistic screening has been undervalued and is more cost-effective than
population screening. It works best in generalist practice. Over 19 consecutive years, all 429 pa-
tients with type 2 diabetes in one NHS general practice were analysed. The prevalence of type 2
diabetes rose from 1.1% to 3.0% of the registered population. Since 2000, 95.9% were diagnosed
within the general practice and the majority (70/121 = 57.9%) of diagnoses were made before the
patients reported any diabetes-related symptom. These patients had median HbA1c levels 1.1%
lower than patients diagnosed after reporting symptoms, a clinically and statistically significant
difference (P = 0.01).
Introduction
Diabetes is a disease of international importance. It is
increasing in prevalence,1 is a lifelong condition, is as-
sociated with serious complications and shorter life ex-
pectation.2 Type 2 diabetes mellitus (T2DM) forms
90% of new diagnoses.3 Most diagnoses of diabetes
are now made in general practice,3 and over two-thirds
of patients with diabetes are now managed in general
practice.4 Diabetes has therefore become a disease of
general practice. Treatment can only follow diagnosis,
so an important research question is how early in the
disease can the diagnosis be made?
Aims
There were three aims of the study:
(i) To identify where diagnoses of diabetes were
made, in particular to ascertain how many were
made in general practice.
(ii) To determine if diagnoses of T2DM could be
made before patients complained of any diabe-
tes-related symptom.
(iii) To determine, if such pre-symptomatic diagnoses
can be made, whether the patients’ HbA1c levels
are then significantly lower.
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The Practice and the method used
This retrospective cohort study was undertaken in the
St Leonard’s Research General Practice (Exeter, UK)
which has 6791 registered National Health Service
(NHS) patients. Each patient diagnosed since 1987 was
entered into the cohort and then followed until trans-
fer out of the Practice, death, or continuing registra-
tion. The age–sex composition of the population is
representative, but the proportion of ethnic minority
patients is lower than the UK average. The Practice
was approved as a Research Practice in 1998. Personal
lists5 which foster patient–doctor relationships and
clinical responsibility have been used since 1974. Med-
ical records have been computerized since 1983. The
median duration of registration of all registered pa-
tients in the Practice is 9 years 2 months. Previous
publications from this Practice have been on diabetes6
and its risk factors.7
Diagnosis of diabetes
The criteria for making a diagnosis of diabetes followed
internationally accepted criteria. From 1988 onwards,
diabetes was diagnosed by an oral glucose tolerance
test.8 In addition, since 1997, the American Diabetes
Association criteria of two fasting blood glucose tests
of 7 mmol/l or more has also been used.9 Patients were
considered to have T2DM if patients presented after
the age of 35 and not needing insulin for at least a year
after diagnosis (as in our previous study).6
Clinical opportunistic screening in the Practice con-
sisted of blood glucose tests for patients at risk of
T2DM, i.e. with coronary heart disease, hypercholes-
terolaemia, hypertension, obesity, skin infections and
those with a positive family history of diabetes.
Data analysed
The Practice database (Vision) was searched for pa-
tients diagnosed with diabetes between January 1,
1987, and April 1, 2006. Data included date of birth,
date registered, gender, family history of diabetes,
date of diagnosis, recorded symptoms at diagnosis,
body mass index at diagnosis and HbA1c result. The
data were validated (from clinical notes) and informa-
tion was added to the records within an Access data-
base including classification as Type 1 or Type 2
diabetes, whether previously diagnosed as having dia-
betes before entering the Practice, whether diagnosed
after registration within the Practice or elsewhere
(e.g. hospital) and year of transfer out of the Practice
or death. Prevalence was calculated as a point preva-
lence using the list size each January 1.
Subgroup analysis
The local pathology laboratory started using the Dia-
betes Control and Complications Trial (DCCT)
corrected internationalized form (Read code 42w.00)
of HbA1c after April 1, 2000. To compare HbA1c lev-
els at diagnosis, a subgroup was identified of all pa-
tients whose HbA1c was reported after 2000. An
HbA1c reading within 60 days of diagnosis was re-
quired for inclusion. Each patient with T2DM was
classified as symptomatic or asymptomatic according
to the symptoms recorded in the NHS medical record.
Any single symptom associated with diabetes in stan-
dard medical texts led to the categorization of ‘symp-
tomatic’.
Five patients, whilst registered, whose diagnosis had
been made outside the Practice whether by a hospital
or a pharmacist, were separately identified and classi-
fied as a symptomatic presentation of the disease.
Using a representative SD of 2.2% for HbA1c in
patients with newly diagnosed diabetes,10 it was esti-
mated that 64 patients in each group (symptomatic
and asymptomatic) would be needed to give 80%
power at a 5% significance level to detect a difference
of 1.1% which was considered to be clinically meaning-
ful. Analyses were conducted using statistical tests of
inference dependent on the data distribution (Table 1).
We used chi-square or Mann–Whitney tests for non-
parametric data and t-tests for parametric comparisons.
Results
A total of 483 people with diabetes were identified
over the 19 years. Of these, 429 (88.8%) had T2DM
and were eligible for the cohort (Fig. 1).
Prevalence of T2DM in the Practice
A total of 2303 patient-years were available for analy-
sis. The prevalence of patients with T2DM rose from
1.1% in 1987 to 3.0% in 2006 (Fig. 2). The annual inci-
dence of T2DM also rose three-fold from a rate of 0.6
per 1000 registered patients in 1987 to 1.9 per 1000 pa-
tients in 2005.
TABLE 1 Characteristics of patients diagnosed in the Practice with
T2DM (April 2000–March 2006)
Asymptomatic,
n = 52
Symptomatica,
n = 36
P-value
Male (%) 32 (70) 14 (30) 0.061b
Median (IQR) age at
diagnosis (years)
64 (20.5) 63 (16) 0.78c
Median (IQR) body
mass index at
diagnosis (kg/m2)
30.8 (9) 32.1 (6.8) 0.78c
Median (IQR)
HbA1c (%)
7.45 (IQR = 1.98) 8.2 (IQR = 4.2) 0.01c
aExcludes the five patients diagnosed outside the Practice.
bStatistical test types: chi-square, Yates’ continuity correction
cMann–Whitney.
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Asymptomatic diagnosis within the subgroup
Since April 1, 2000 (when internationalized HbA1c lev-
els were available), 121 registered patients were diag-
nosed with T2DM. Of these, 116 (95.9%) were
diagnosed within the Practice and 70 were diagnosed
without symptoms (57.9%). Of these 121, 88 (76%)
had an eligible HbA1c, there being 46 males and 42 fe-
males with a mean age at diagnosis of 62.5 years (95%
CI = 59.7–65.3). Those diagnosed without any symp-
toms of diabetes were in the majority (52/88 = 59.1%).
Although we did not obtain the sample size identified
theoretically in the power calculation, we nevertheless
found statistically significant differences in HbA1c be-
tween the two groups. The median HbA1c level at di-
agnosis for those patients presenting with symptoms
was 8.2% [interquartile range (IQR) = 4.2]. The me-
dian HbA1c for those diagnosed before symptoms was
7.45% (IQR = 1.98). The median difference was 1.1%
(95% CI = 0.3–2.3%; P = 0.01). No other significant
differences were seen between the two groups.
FIGURE 1 Categories of patients used in analysis
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Discussion
There are two perspectives on this work: the role of
research in single general practices and clinical oppor-
tunistic screening. Both are undervalued, yet both are
important to the discipline of general practice.
Research in single general practices
Many recent general practice studies report from multi-
ple large databases, which are essential for rarer condi-
tions. Concern has been expressed to DPG (MRC
Committee Chairman, personal communication) that
single-practice studies may not be generalizable. This is
true but some well-known single-practice studies re-
searched local problems11,12 and hypotheses which were
later confirmed in bigger studies. For example, a single-
practice study showing adverse consequences of loss of
continuity13 was later confirmed by Menec et al.14
Single general practices have several advantages for
research as, for common conditions, there can be sev-
eral hundred patients available for analysis. Clinicians
can add useful information such as two women with
different names being sisters, clinicians can be asked
to complete missing values and additional information,
e.g. from death certificates, can be available. The con-
cept ‘living epidemiology’, coined in this Practice in
1994, embraces these features.15
Clinical opportunistic screening
Clinical opportunistic screening is defined as a clinical
process in which a health professional uses a consultation
with a patient to consider the possibility of the patient
having a condition other than that for which advice
was sought. It is of particular importance in relation
to serious conditions like alcoholism, depression, dia-
betes and hypertension. Clinical opportunistic screen-
ing can be used in any clinical setting. For example,
some hospital departments have screened in-patients
for alcoholism using the CAGE (Cut down, Annoyed,
Guilty, Eye-opener) questionnaire.16
However, clinical opportunistic screening is most ef-
ficient and probably more cost effective in primary
rather than secondary or tertiary care, for several rea-
sons. First, because of the high-contact UK general
practice has with the population as a whole, 13% of
the population attends a general practice every fort-
night and the average contact between citizens is now
as high as five consultations per person per year.17
Also, average general practice contacts with the over-
75s are as high as seven consultations per year and
T2DM is an age-related condition.18 Thirdly, GPs are
medical generalists and, alone amongst clinicians, are
as concerned with mental as with physical conditions,
e.g. treating depression and diabetes in the same con-
sultation. Generalists can manage the widest range of
medical conditions and are less likely than a special-
ized department to need to refer to another setting, in-
creasing the efficiency of the process. Fourthly,
diagnosis in general practice/primary care works on
the basis of probabilities and clinical opportunistic
screening fits this approach.
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FIGURE 2 Factors determining the prevalence of Type 2 diabetes in the Practice
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Comparison with population screening
Population screening is a process whereby people are
invited for screening on the basis of address, geo-
graphical area or list. This process is more expensive
per person screened as people have to be identified,
invited (some decline) and then informed of the result.
Population screening requires a referral of those who
test positive to their general practitioners. Some pa-
tients do not attend and many of those testing positive
will not have the disease in question. Screening teams
do not provide care or follow-up.
Population screening has been tried for T2DM on
several occasions and in several places. It always finds
some cases but at relatively high cost. Population
screening for diabetes is not currently recommended
in either the UK or the US.
By comparison, clinical opportunistic screening has
no costs in making the initial appointment which is
made by the patient for some other reason, there is
only marginal extra time taken and the additional cost
is only the extra blood glucose tests (which are very
cheap). The cost of informing the patient of negative
results falls to the usual practice system (such as the
patient telephoning for the result). There are extra
costs in contacting the patient if the glucose is re-
ported to be raised, but now this is usually in the con-
text of an early diagnosis. Furthermore, the patient is
informed by their own doctor, whom they know and
treatment, once the diagnosis has been confirmed, can
start at once managed by the patient’s usual doctor.
Clinical opportunistic screening requires high pro-
fessional morale and interested, confident clinicians.
These doctors are doing more than is usual in their
consultations. It has recently been made more practi-
cal by the lengthening of the average consultation in
general practice in the UK NHS to 13 minutes.17
Clinical opportunistic screening is a more cost-
effective approach and one working within the main
NHS system. It has not received much academic atten-
tion, perhaps, because there have been few reports like
this showing its potential. Clinical opportunistic screen-
ing in UK general practice can approximate to popula-
tion screening in terms of coverage since 90% of the
population sees a GP every year.19
Diagnosing diabetes before symptoms
Diagnosing diabetes before symptoms occur is a partic-
ularly important form of pre-symptomatic diagnosis.
Diabetes is a common and important disease which
produces serious clinical complications and shortens
life by an average of 20 years.2 The large UK Prospec-
tive Diabetes Study reported some new diagnoses of
diabetes by screening.20 Patients with symptoms had a
mean HbA1c at diagnosis of 9.6% and those patients
with diabetes detected by screening 8.1%. Both levels
are higher than reported here, suggesting that continu-
ous, clinical opportunistic screening in primary care
may have advantages. The difference between mean
HbA1c levels in the two groups of 1.5% was slightly
larger than that reported in this study.
A different result was reported from the Nether-
lands in the Hoorn screening study.21 This found that
screening-detected patients had a mean HbA1c of
only 6.7% and compared these with new diagnoses in
general practices where the mean HbA1c was 9.1%.
However, two different populations were used rather
than the same population as in this study and they did
not describe the diagnostic processes or state of com-
puterization of the general practices. Their screened
group comprised volunteers who may not be typical
of a local population. Thus, when first diagnosed, peo-
ple in Europe with symptoms of T2DM commonly
have an HbA1c as high as 9.1–9.6%.
Comments on findings
Since the local laboratory did not adopt DCCT meth-
odology until the year 2000, numbers are limited. The
clinical records did not include HbA1c in the time
stipulated for 33 patients, further reducing numbers
available for analysis. The main findings of diagnosis
before symptoms and significantly lower HbA1c with
asymptomatic diagnosis, exciting though they are, can-
not be generalized without further studies.
Conclusions
This preliminary report from one general practice
shows that
(i) Over 19 consecutive years, the prevalence of
T2DM rose from 1.1% to 3.0% of the registered
population.
(ii) Of all the diagnoses of T2DM made since 2000,
95.9% were made by general practitioners within
the practice.
(iii) Of 121 new diagnoses of T2DM since 2000, a
majority 70 (57.9%) were made, by clinical
opportunistic screening, i.e. before the patients
complained of any diabetes-related symptom.
(iv) Those patients diagnosed before reporting any
diabetic symptoms with eligible HbA1c results
had median HbA1c levels 1.1% lower than pa-
tients who were diagnosed with symptoms. This
is a new finding and is both statistically and clini-
cally significant.
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